This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Incyte Corp. (INCY) shed 1.93% to $100.71 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&amp;P 500 Index  rising 0.64% to 6,878.49 and the Dow Jones Industrial Average  rising 0.47% to 48,362.68.
Incyte Corp. closed 7.84% below its 52-week high of $109.28, which the company reached on November 12th.
The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Alnylam Pharmaceuticals Inc. (ALNY) rose 1.87% to $407.73, Bio-Techne Corp. (TECH) rose 1.18% to $58.96, and BioMarin Pharmaceutical Inc. (BMRN) fell 3.06% to $59.28.
Data source: Dow Jones Market Data, FactSet. Data compiled December 22, 2025.
This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
12-22-25 1708ET

INCY

<p>Incyte Corp.'s stock fell 1.93% to $100.71 on Monday, underperforming compared to competitors like Alnylam Pharmaceuticals and Bio-Techne, which saw gains. The stock is 7.84% below its 52-week high. The S&P 500 and Dow Jones both rose during the session.</p>

Incyte Corp. Stock Underperforms Monday When Compared To Competitors